- Ventricular tachycardia (VT) is a rapid heart rhythm originating from the lower chambers of the heart — more serious than most arrhythmias, but very manageable with the right specialist care.
- Not all VT is equally dangerous. Brief episodes in a structurally normal heart carry a very different risk profile to sustained VT in someone with significant cardiomyopathy.
- The most common underlying cause is structural heart disease — particularly scarring from a previous heart attack. Treating the underlying condition directly reduces VT risk.
- Treatment options are effective — medications, an implantable defibrillator (ICD), and catheter ablation all have important roles depending on the clinical situation.
- VT is managed by cardiac electrophysiologists — specialist cardiologists with specific training in the heart’s electrical system. Being referred to one is appropriate, not alarming.
A diagnosis of ventricular tachycardia understandably feels significant. Unlike SVT — which arises from the upper chambers and is almost always benign — VT originates from the ventricles, the heart’s main pumping chambers, and in certain circumstances can have serious consequences.
But serious does not mean unmanageable. The tools available to treat VT today — medications, implantable defibrillators, and catheter ablation — are highly effective. Most people with VT, properly diagnosed and under the right specialist care, do well.
Understanding what VT is, why it happens, and what treatment involves is the most important first step toward feeling in control of this diagnosis.
What Is VT?
The basics
Ventricular tachycardia is a rapid heart rhythm starting from the ventricles — the lower chambers — at a rate of 100 beats per minute or more. In practice, most clinically significant VT occurs well above 150 beats per minute. On an ECG, the beats appear broad and abnormal, reflecting the fact that the electrical signal is travelling through the heart muscle in an unusual direction.
The key distinction from SVT is where the rhythm originates. SVT starts above the ventricles and the ventricles follow. In VT, the ventricles are driving the rhythm themselves — which is why it has greater potential to compromise the heart’s pumping function.
Types of VT — and why they matter
| Type | What it means | Clinical significance |
|---|---|---|
| Non-sustained VT (NSVT) | Terminates spontaneously within 30 seconds | Often asymptomatic — significance depends heavily on underlying heart condition |
| Sustained VT | Persists more than 30 seconds or requires intervention | Requires prompt assessment and treatment |
| Monomorphic VT | Consistent QRS shape — suggests a single stable circuit | Most common form — often amenable to ablation |
| Polymorphic VT | Changing QRS shape with each beat | More often linked to acute ischaemia or genetic conditions — higher risk of deterioration |
What Causes VT?
Structural heart disease — the most common cause
The majority of VT occurs in people with underlying structural heart disease — most commonly scarring from a previous heart attack. When heart muscle is damaged, the scar tissue doesn’t conduct electrical signals normally. The border zone between scar and healthy muscle creates regions where electrical impulses can get trapped in a rapid loop — the substrate for VT.
This is why treating the underlying heart condition — optimising heart failure therapy, managing coronary artery disease — directly reduces VT risk. The arrhythmia and the underlying disease are not separate problems.
Cardiomyopathies
Dilated cardiomyopathy, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy (ARVC) all create structural and fibrotic changes that predispose to ventricular arrhythmia. Heart failure with significantly reduced pump function amplifies this risk further.
Inherited conditions — important in younger patients
In younger patients without obvious structural disease, VT can arise from inherited electrical conditions — Long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic VT (CPVT) among them. These are important to identify because the management differs substantially from scar-related VT, and family screening may be needed.
Reversible causes
Severe electrolyte disturbances — particularly low potassium or magnesium — drug toxicity, myocarditis, and acute ischaemia can all trigger VT. These are always considered and excluded early, because correcting them may remove the need for long-term device therapy entirely.
What Does VT Feel Like?
Symptoms depend on how fast the VT is, how long it lasts, and how well the underlying heart is functioning. At lower rates or in brief episodes, some people feel very little — perhaps mild palpitations or dizziness. At higher rates, or with impaired cardiac function, VT can cause significant breathlessness, chest discomfort, near-fainting, or loss of consciousness.
Non-sustained VT is often discovered incidentally — picked up on a Holter monitor worn for another reason, with no symptoms at all. Finding it is not automatically alarming — its significance depends entirely on the clinical context.
I always tell patients that the first question with any VT diagnosis is not just “what rhythm is this?” — it’s “what is the heart underneath it doing?” A few beats of NSVT in a structurally normal heart is a very different situation to the same finding in someone with a significantly weakened ventricle. Context is everything.
Diagnosis and Investigation
Capturing the rhythm
A 12-lead ECG during an episode is the most valuable piece of diagnostic information available. One of the important — and sometimes challenging — tasks in cardiology is distinguishing VT from SVT with aberrant conduction, both of which produce a broad-complex tachycardia on the ECG. The distinction has significant management implications, which is why specialist ECG interpretation matters.
Understanding the heart underneath
Beyond the ECG, investigation of VT involves thorough assessment of the underlying heart structure and function. An echocardiogram defines ventricular function and identifies structural abnormalities. Cardiac MRI characterises myocardial fibrosis and scar — both important for understanding VT mechanism and risk. Coronary angiography may be indicated if ischaemia is suspected.
For patients being considered for ablation, an electrophysiology study maps the heart’s electrical system in detail, induces VT under controlled conditions, and identifies the precise circuit responsible.
Treatment Options
Acute treatment
Haemodynamically unstable VT — where the blood pressure is compromised and the patient is deteriorating — requires immediate electrical cardioversion to restore normal rhythm. Stable VT can often be terminated with intravenous antiarrhythmic medication such as amiodarone, though cardioversion remains available if needed.
Medications for ongoing management
Beta-blockers, amiodarone, and sotalol are the main antiarrhythmic agents used to suppress VT and reduce episode frequency. Amiodarone is highly effective but carries a significant long-term side effect profile — thyroid, liver, lung, and skin effects — which requires regular monitoring. The right agent depends on the underlying heart condition and individual tolerability.
The ICD — a safety net, not a cure
An implantable cardioverter-defibrillator is recommended for patients at elevated risk of sudden cardiac death from VT or ventricular fibrillation. It monitors heart rhythm continuously and responds automatically — first with antitachycardia pacing, a rapid burst of pacing that can terminate VT painlessly, and if needed with a defibrillation shock.
An important point worth understanding: an ICD does not prevent VT from occurring. It provides a reliable safety net when it does. Reducing VT frequency — through medication, ablation, and optimising the underlying heart condition — remains the goal alongside device protection.
Catheter ablation
Catheter ablation has become an increasingly important treatment for VT, particularly for scar-related VT in structural heart disease and for idiopathic VT in structurally normal hearts. Using three-dimensional electroanatomic mapping, electrophysiologists precisely identify the circuit driving the VT and deliver radiofrequency energy to eliminate it.
In experienced centres, ablation can significantly reduce VT burden, reduce ICD shocks, and in some patients achieve long-term freedom from VT episodes. It is not a simple procedure — but the results in the right hands are meaningful.
- Is my VT sustained or non-sustained — and what does that mean for my risk and management?
- What is the underlying cause of my VT, and is there additional treatment for the underlying heart condition?
- Am I a candidate for catheter ablation, and what would that involve at your centre?
- If I have an ICD — what should I do if it fires, and when should I contact the device clinic?
- Are there triggers I should specifically avoid — electrolytes, stimulants, missed medications?
Heart Matters Resource
When in Doubt, Get Checked Out
If you experience a sudden rapid heart rate, dizziness, chest discomfort, or near-fainting — particularly if you have known heart disease — seek urgent assessment. An ECG during the episode is the single most valuable piece of diagnostic information.
Conclusion
Ventricular tachycardia commands serious attention — and the specialist care it receives reflects that. But serious is not the same as hopeless, and the tools available today are genuinely effective.
Most people with VT, under the care of an experienced electrophysiologist and with the underlying heart condition properly managed, do well. The combination of medications, ICD protection where needed, and catheter ablation where appropriate gives clinicians a powerful toolkit — and gives patients real reason for optimism.
If you have been diagnosed with VT, the most important steps are ensuring you are under specialist electrophysiology care, understanding your treatment and why it matters, and actively managing any underlying heart condition alongside the arrhythmia itself.
